Minimizing door-to-balloon time is not the most critical factor in improving clinical outcome of ST-Elevation myocardial infarction patients undergoing primary percutaneous coronary intervention

Critical Care Medicine

Volumn 42, Issue 8, 2014, Pages 1788-1796

  Ho, Yuan Chih ^a   Tsai, Tzu Hsien ^a   Sung, Pei Hsun ^a   Chen, Yung Lung ^a   Chung, Sheng Ying ^a   Yang, Cheng Hsu ^a   Chen, Shyh Ming ^a   Chen, Chien Jen ^a   Fang, Hsiu Yu ^a   Wu, Chiung Jen ^a   Yip, Hon Kan ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

30 day clinical outcome; door to balloon time; STelevation myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CREATINE KINASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPERTENSIVE AGENT; INOTROPIC AGENT;

ADULT; ARTICLE; BARE METAL STENT; CARDIOGENIC SHOCK; CAROTID ARTERY STENTING; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; DRUG ELUTING STENT; EMBOLIC PROTECTION DEVICE; EXTRACORPOREAL OXYGENATION; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REPERFUSION; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; THORAX PAIN; THROMBECTOMY; TIME TO TREATMENT; TRANSTHORACIC ECHOCARDIOGRAPHY; AGED; HOSPITAL MORTALITY; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; TERTIARY CARE CENTER; TIME FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; AGED; ANGIOPLASTY, BALLOON, CORONARY; COHORT STUDIES; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; TERTIARY CARE CENTERS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84904725615     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000329     Document Type: Article

References (25)

1. Hao K, Yasuda S, Takii T, et al; MIYAGI-AMI Study Investigators: Urbanization, life style changes and the incidence/in-hospital mortality of acute myocardial infarction in Japan: Report from the MIYAGI-AMI Registry Study. Circ J 2012; 76:1136-1144
2. Chen J, Hsieh AF, Dharmarajan K, et al: National trends in heart failure hospitalization after acute myocardial infarction for Medicare benefciaries: 1998-2010. Circulation 2013; 128:2577-2584
3. Yip HK, Wu CJ, Chang HW, et al: Comparison of impact of primary percutaneous transluminal coronary angioplasty and primary stenting on short-term mortality in patients with cardiogenic shock and evaluation of prognostic determinants. Am J Cardiol 2001; 87:1184-1188; A4
4. Danchin N, Coste P, Ferrieres J, et al: Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: Data from the French registry on acute ST-elevation myocardial infarction (FAST-MI). Circulation 2008; 118:268-276
5. De Luca G, Cassetti E, Marino P: Percutaneous coronary intervention-related time delay, patient's risk profle, and survival benefts of primary angioplasty vs lytic therapy in ST-segment elevation myocardial infarction. Am J Emerg Med 2009; 27:712-719
6. Yip HK, Chen MC, Chang HW, et al: Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: Predictors of slow-fow and no-refow phenomenon. Chest 2002; 122:1322-1332
7. Keeley EC, Boura JA, Grines CL: Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 2003; 361:13-20
8. Andersen HR, Nielsen TT, Rasmussen K, et al; DANAMI-2 Investigators: A comparison of coronary angioplasty with fbrinolytic therapy in acute myocardial infarction. N Engl J Med 2003; 349:733-742
9. Keeley EC, Boura JA, Grines CL: Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: Quantitative review of randomised trials. Lancet 2006; 367:579-588
10. Di Mario C, Dudek D, Piscione F, et al; CARESS-in-AMI (Combined Abciximab RE-teplase Stent Study in Acute Myocardial Infarction) Investigators: Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): An open, prospective, randomised, multicentre trial. Lancet 2008; 371:559-568
11. Cantor WJ, Fitchett D, Borgundvaag B, et al; TRANSFER-AMI Trial Investigators: Routine early angioplasty after fbrinolysis for acute myocardial infarction. N Engl J Med 2009; 360:2705-2718
12. O'Gara PT, Kushner FG, Ascheim DD, et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013; 127:e362-e425
13. Hannan EL, Zhong Y, Jacobs AK, et al: Effect of onset-to-door time and door-to-balloon time on mortality in patients undergoing percutaneous coronary interventions for ST-segment elevation myocardial infarction. Am J Cardiol 2010; 106:143-147
14. Brodie BR, Gersh BJ, Stuckey T, et al: When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trials. J Am Coll Cardiol 2010; 56:407-413
15. Sheu JJ, Tsai TH, Lee FY, et al: Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock. Crit Care Med 2010; 38:1810-1817
16. Yip HK, Wu CJ, Chang HW, etal: Effect of the PercuSurge GuardWire device on the integrity of microvasculature and clinical outcomes during primary transradial coronary intervention in acute myocardial infarction. Am J Cardiol 2003; 92:1331-1335
17. Cheng CI, Yeh KH, Chang HW, et al: Comparison of baseline characteristics, clinical features, angiographic results, and early outcomes in men vs women with acute myocardial infarction undergoing primary coronary intervention. Chest 2004; 126:47-53
18. Svilaas T, Vlaar PJ, van der Horst IC, et al: Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 2008; 358:557-567
19. Menees DS, Peterson ED, Wang Y, et al: Door-to-balloon time and mortality among patients undergoing primary PCI. N Engl J Med 2013; 369:901-909
20. Yip HK, Wu CJ, Chang HW, et al: Comparison of primary angioplasty and conservative treatment on short-and long-term outcome in octogenarian or older patients with acute myocardial infarction. Jpn Heart J 2002; 43:463-474
21. Tsai TH, Chai HT, Sun CK, et al: Comparison of 30-day mortality between anterior-wall versus inferior-wall ST-segment elevation myocardial infarction complicated by cardiogenic shock in patients undergoing primary coronary angioplasty. Cardiology 2010; 116:144-150
22. Widimsky P, Bilkova D, Penicka M, et al: Long-term outcomes of patients with acute myocardial infarction presenting to hospitals without catheterization laboratory and randomized to immediate thrombolysis or interhospital transport for primary percutaneous coronary intervention. Five years' follow-up of the PRAGUE-2 Trial. Eur Heart J 2007; 28:679-684
23. McManus DD, Chinali M, Saczynski JS, et al: 30-year trends in heart failure in patients hospitalized with acute myocardial infarction. Am J Cardiol 2011; 107:353-359
24. Kelly DJ, Gershlick T, Witzenbichler B, et al: Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: The HORIZONS-AMI trial. Am Heart J 2011; 162:663-670
25. French JK, Armstrong PW, Cohen E, et al: Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: Observations from "Assessment of Pexelizumab in Acute Myocardial Infarction". Am Heart J 2011; 162:89-97